NOVALIQ
LIVE

Serial Number

98412212

Owner

Novaliq GmbH

Attorney

Lily Ackerman

Filing Date

Feb 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

NOVALIQ Trademark

Serial Number: 98412212 • Registration: 8017341

NOVALIQ is a trademark filed by Novaliq GmbH on February 20, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Novaliq GmbH

Im Neuenheimer Feld 515

Entity Type: 27

Trademark Details

Filing Date

February 20, 2024

Registration Date

November 11, 2025

Published for Opposition

January 14, 2025

Goods & Services

Medical and pharmacological research services; scientific research for medical purposes; chemical research and analysis services; scientific laboratory services; development of pharmaceutical preparations and medicines; scientific and technological consultancy relating to the syntheses and production of pharmaceuticals; clinical research in the fields of ophthalmic pharmaceutical preparations, dermatologic pharmaceutical preparations, semifluorinated alkanes (SFAs) and of topical medical treatments; testing, authentication and quality control for others in the field of semifluorinated alkanes (SFAs) and of water-free pharmaceutical preparations.

Anti-infectives; veterinary pharmaceutical preparations for treatment of ophthalmic disease; pharmaceutical preparations for ophthalmic use; medicinal preparations and pharmaceutical substances for ophthalmic use; liquid and semisolid pharmaceutical compositions for the treatment of eye diseases; eye drops; pharmaceutical preparations for the treatment of the dry eye disease; pharmaceutical preparations for the treatment of ocular surface diseases; pharmaceutical preparations for use in dermatology; medicated preparations for skin treatment; antimicrobials for dermatologic use; anti-dermoinfectives; pharmaceutical preparations for dental use; pharmaceutical preparations for the treatment of posterior eye diseases; pharmaceutical preparations for topical use for treating dermatologic conditions; pharmaceutical water-free preparations (exclusive medicaments, medicines), namely aids in the nature of veterinary pharmaceutical preparations for topical treatment of eye diseases and disorders and active substances comprising semifluorinated alkanes (SFAs) being medical aids.

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 15, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 15, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 15, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 15, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2025 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 24, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 24, 2025 REAP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 24, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 24, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 24, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2025 EXRA
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 17, 2025 DP1B
NOTICE OF ALLOWANCE CANCELLED
Oct 17, 2025 IUCN
SOU EXTENSION 1 GRANTED
Oct 17, 2025 EX1G
PETITION TO DIRECTOR DISMISSED
Oct 17, 2025 PC.D
ASSIGNED TO PETITION STAFF
Oct 16, 2025 APET
SOU EXTENSION 1 FILED
Sep 10, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 10, 2025 EEXT
TEAS PETITION TO AMEND BASIS RECEIVED
Sep 9, 2025 TPAD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 25, 2024 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 23, 2024 PARI
NEW APPLICATION ENTERED
Feb 20, 2024 NWAP